Chimin Health Management Co., Ltd. (SHA:603222)

Market Cap	4.63B +48.0%
Revenue (ttm)	668.04M -7.6%
Net Income	-257.87M
EPS	-0.48
Shares Out	513.45M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,003,500
Open	9.01
Previous Close	9.07
Day's Range	8.82 - 9.14
52-Week Range	5.84 - 15.10
Beta	0.44
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 30, 2026

About Chimin Health Management

Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells vitro diagnostic products and provides medical services in China and internationally. The company provides non-PVC double-tube double-valve, single-tube single-valve, and single-tube double-valve soft bags; plastic bottles; and other packaging forms. It also offers medical instruments, including safety syringes, safety injection needles, sterile syringes, dispensers, insulin syringes, infusion sets, precision filter infusion sets, and o...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1996
• Employees: 1,890
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603222

Financial Performance

In 2025, Chimin Health Management's revenue was 685.96 million, a decrease of -11.57% compared to the previous year's 775.73 million. Losses were -245.58 million, 311.3% more than in 2024.